Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure.

Journal Article (Clinical Trial;Journal Article;Multicenter Study)

Full Text

Duke Authors

Cited Authors

  • Gheorghiade, M; Gattis, WA; Barbagelata, A; Adams, KF; Elkayam, U; Orlandi, C; O'Connor, CM; Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure Investigators,

Published Date

  • February 2003

Published In

Volume / Issue

  • 145 / 2 Suppl

Start / End Page

  • S51 - S54

PubMed ID

  • 12594452

Electronic International Standard Serial Number (EISSN)

  • 1097-6744

Digital Object Identifier (DOI)

  • 10.1067/mhj.2003.154


  • eng

Conference Location

  • United States